Evidence map›Paper›PMID 16552004›Full record

ArticleAJNR. American journal of neuroradiology2006

Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice.

E Bullitt, P A Wolthusen, L Brubaker, W Lin, D Zeng, T Van Dyke

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00630292 (Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00630292 naterminatednot on this mapstarted 2008, after this paper: background citation

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2008 to 2009Enrolled6ConditionsBreast CancerArmsMagnetic Resonance Angiography (MRA) of the Breast
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Predicting drug delivery efficiency into tumor tissues through molecular simulation of transport in complex vascular networks.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vascular tortuosity: a mathematical modeling perspective.The journal of physiological sciences : JPS · 2012
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E BullittDepartment of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
P A Wolthusen
L Brubaker
W Lin
D Zeng
T Van Dyke
University of North Carolina at Chapel Hill · US

Funding

3D Cerebral Vessel Location for Surgical PlanningR01EB000219 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BULLITT, ELIZABETH · 2002 to 2008
$3.0M
NIBIB NIH HHS R01 EB000219
6 · The paper itself

Abstract

background and purposeThe ability to assess tumor malignancy and monitor treatment response noninvasively would be of value to both clinicians and animal investigators. This report describes the MR imaging characteristics of a genetically engineered mouse model of choroid plexus carcinoma (CPC) during tumor growth and progression to malignancy. We assess the ability of vessel tortuosity measurements, as calculated from high-resolution MR angiographic (MRA) images, to detect emerging CPC cancers.

methodsMR images of 9 healthy mice and of 20 CPC mice with precancerous choroid dysplasia or with cancer over a wide range of sizes were analyzed. Two vessel tortuosity measures and a measure of vessel attenuation (vessel count) were calculated from MRA images. Malignancy assessment was based upon a statistical analysis of vessel tortuosity, by using an equation derived from an earlier study of human brain tumor patients.

resultsChoroid dysplasia was correctly judged nonmalignant. On the basis of vessel count, neoangiogenesis could not be detected until cancers were full-blown and had reached a volume of approximately 80 mm3. Vessel tortuosity measurements, however, correctly identified emerging malignancy in lesions larger than 0.3 mm3.

conclusionTo the best of our knowledge, this report provides the first description of in vivo, MR imaging characteristics of genetically engineered CPC mice during the progression from dysplasia to cancer. Vessel tortuosity measurements offer promise of correctly defining even tiny tumors as malignant.

Indexed as

Diagnosis, Computer-AssistedMagnetic Resonance AngiographyAnimalsAnimals, Genetically ModifiedCarcinomaChoroid Plexus NeoplasmsMice

Identifiers

PMID16552004
PMCPMC2504702
OpenAlexW1952239748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.